Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tate & Lyle ( (GB:TATE) ) has issued an update.
Tate & Lyle PLC announced a transaction involving Claudia Vaz de Lestapis, a non-executive director, and Alexandre Samuel Pierre Marie de Lestapis, who acquired 2,500 American Depositary Receipts (ADRs) at a price of US$20.16 each. This acquisition increases their total holding to 5,000 ADRs, equivalent to 20,000 ordinary shares, and was conducted on the OTCQX exchange. This transaction reflects the confidence of key stakeholders in the company’s future prospects and complies with the Market Abuse Regulation.
The most recent analyst rating on (GB:TATE) stock is a Buy with a £4.60 price target. To see the full list of analyst forecasts on Tate & Lyle stock, see the GB:TATE Stock Forecast page.
Spark’s Take on GB:TATE Stock
According to Spark, TipRanks’ AI Analyst, GB:TATE is a Neutral.
Tate & Lyle’s overall stock score is driven by strong earnings call highlights, including strategic growth and robust EBITDA performance. Financial stability and a reasonable dividend yield support the score, though technical indicators and valuation suggest caution.
To see Spark’s full report on GB:TATE stock, click here.
More about Tate & Lyle
Tate & Lyle PLC operates in the food and beverage industry, specializing in the production of ingredients and solutions that enhance the taste, texture, and nutritional profile of products. The company is known for its expertise in sweeteners, texturants, and health and wellness ingredients, catering to a global market.
Average Trading Volume: 1,414,863
Technical Sentiment Signal: Sell
Current Market Cap: £1.61B
For an in-depth examination of TATE stock, go to TipRanks’ Overview page.